Ablation of pulmonary oligometastasis in advanced hepatocellular carcinoma treated with Lenvatinib: a retrospective multicenter study
Therapeutic Advances in Medical Oncology
Published online on March 19, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:In patients with hepatocellular carcinoma (HCC) and pulmonary oligometastasis (PO), the therapeutic effects of metastases ablation remain unclear.Objective:This study aimed to compare the efficacy of metastases ablation combined with Lenvatinib ...
Background:In patients with hepatocellular carcinoma (HCC) and pulmonary oligometastasis (PO), the therapeutic effects of metastases ablation remain unclear.Objective:This study aimed to compare the efficacy of metastases ablation combined with Lenvatinib ...